DGIdb - PREDNISONE Drug Record

PREDNISONE chembl:CHEMBL635 ApprovedAntineoplasticImmunotherapy

Alternate Names:

CORTANCYL
PREDNISONE INTENSOL
STERAPRED
NSC-10023
PREDNISONE TABLETS
PREDNICEN-M
METICORTEN
RAYOS
PARACORT
FERNISONE
LIQUID PRED
LODOTRA
ORASONE
SERVISONE
DELTA-DOME
CORTAN
DECORTISYL
PREDNISONE
DELTASONE
DEHYDROCORTISONE
LODOTRA®
STERAPRED®
17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE
PREDNISONUM
1,4-PREGNADIENE-17ALPHA,21-DIOL-3,11,20-TRIONE
PREDNISONA
1,2-DEHYDROCORTISONE
PREDNISON
rxcui:8640
chembl:CHEMBL635
drugbank:00635
chemidplus:53-03-2
pubchem.compound:5865

Drug Info:

Drug Class	glucocorticoids
Year of Approval	approved before 1982
Drug Class	anti-inflammatory agents
FDA Approval	approved
Drug Class	Small Molecule
Drug Indications	antiinflammatory agent,corticosteroid
Drug Categories	intestinal antiinflammatory agents
Drug Categories	adrenals
Drug Categories	corticosteroid hormone receptor agonists
Drug Categories	corticosteroids
Drug Categories	corticosteroids for systemic use
Drug Categories	corticosteroids for systemic use, plain
Drug Categories	cytochrome p-450 cyp2a6 inducers
Drug Categories	cytochrome p-450 cyp2b6 inducers
Drug Categories	cytochrome p-450 cyp2b6 inducers (strength unknown)
Drug Categories	cytochrome p-450 cyp2c19 inducers (strength unknown)
Drug Categories	cytochrome p-450 cyp2c8 inducers
Drug Categories	cytochrome p-450 cyp2c8 inducers (strength unknown)
Drug Categories	cytochrome p-450 cyp2c9 inducers
Drug Categories	cytochrome p-450 cyp2c9 inducers (strength unknown)
Drug Categories	cytochrome p-450 cyp3a substrates
Drug Categories	cytochrome p-450 cyp3a4 inducers
Drug Categories	cytochrome p-450 cyp3a4 inducers (strength unknown)
Drug Categories	cytochrome p-450 cyp3a5 inducers
Drug Categories	cytochrome p-450 cyp3a5 inducers (strength unknown)
Drug Categories	cytochrome p-450 enzyme inducers
Drug Categories	cytochrome p-450 substrates
Drug Categories	drugs that are mainly renally excreted
Drug Categories	fused-ring compounds
Drug Categories	p-glycoprotein inducers
Drug Categories	p-glycoprotein inhibitors
Drug Categories	p-glycoprotein substrates
Drug Categories	prednisolone and prodrugs
Drug Categories	systemic hormonal preparations, excl. sex hormones and insulins
Drug Categories	thyroxine-binding globulin inhibitors

(6 More Sources)

Publications:

Ettinger et al., 1988, Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men., Metab. Clin. Exp.
Anderer et al., 2000, Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia., Pharmacogenetics
Ammersbach et al., The effect of glucocorticoids on canine lymphocyte marker expression and apoptosis., J. Vet. Intern. Med.
Zheng H et al., 2002, The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients., Hum Immunol
Jordheim LP et al., 2015, Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma., Haematologica
Broussolle et al., 1989, Rapid effectiveness of prednisone and thionamides combined therapy in severe amiodarone iodine-induced thyrotoxicosis. Comparison of two groups of patients with apparently normal thyroid glands., J. Endocrinol. Invest.
Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol
Kurzawski M et al., 2005, The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients., Ther Drug Monit
Díez et al., 2007, Pharmacological therapy of Cushing's syndrome: drugs and indications., Mini Rev Med Chem
Yano et al., 2006, Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells., Clin. Cancer Res.
Czock D et al., 2005, Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids., Clin Pharmacokinet
Yano et al., 2006, Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells., Clin. Cancer Res.
Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
Friel et al., 2006, Suppression of adrenal function by low-dose prednisone: assessment with 24-hour urinary steroid hormone profiles--a review of five cases., Altern Med Rev
Liu et al., 2006, [Effects of jingui shenqi pill combined prednisone on expression of glucocorticoid receptor and its clinical effect in treating bullous pemphigoid patients]., Zhongguo Zhong Xi Yi Jie He Za Zhi
Pietrasiewicz et al., Studies on the interaction of antidepressant drugs with adrenocorticotropic hormone or prednisone in rats., Pol J Pharmacol
Perez-Andreu V et al., 2013, Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse., Nat Genet
Lavignac et al., 1996, [Immunohistochemical study of lesions in Horton's temporal arteritis before and during corticotherapy]., Rev Med Interne
Fracchia et al., 2000, Serum interferon gamma in primary biliary cirrhosis: effect of ursodeoxycholic acid and prednisone therapy alone and in combination., Eur J Gastroenterol Hepatol
Karol SE et al., 2016, Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia., Blood
Favis R et al., 2011, Genetic variation associated with bortezomib-induced peripheral neuropathy., Pharmacogenet Genomics
Butrym A et al., 2016, Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia., HLA
Wu et al., 1998, [Clinical study on improving effect of Buyang Huanwu decoction on plasma thromboxane B2, 6-keto-prostaglandin F1 alpha, endothelin and calcitonin gene related peptide in primary nephrotic syndrome patients]., Zhongguo Zhong Xi Yi Jie He Za Zhi
Wender et al., [Myelin basic protein stimulation index of CD 2 cells in the course of steroid treatment]., Neurol. Neurochir. Pol.
Casonato et al., 1988, Factor VIII/von Willebrand factor abnormalities during L-asparaginase treatment in patients with acute lymphoblastic leukemia., Acta Haematol.
Kalra S et al., 2018, Association of CYP2C192 and ALDH1A11/*2 variants with disease outcome in breast cancer patients: results of a global screening array., Eur J Clin Pharmacol
Rossi D et al., 2009, Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21., Leukemia
López-López E et al., 2014, Pharmacogenetics of microRNAs and microRNAs biogenesis machinery in pediatric acute lymphoblastic leukemia., PLoS One

PREDNISONE MBP

Interaction Score: 0.71

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10612091

Sources:
NCI
PREDNISONE DROSHA

Interaction Score: 0.51

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
24614921

Sources:
PharmGKB
PREDNISONE CXCL12

Interaction Score: 0.44

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
27173875

Sources:
PharmGKB
PREDNISONE MC2R

Interaction Score: 0.39

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
9112644

Sources:
NCI
PREDNISONE GSTA1

Interaction Score: 0.38

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
29938344 19448608

Sources:
PharmGKB
PREDNISONE LINC00251

Interaction Score: 0.36

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
26590194

Sources:
PharmGKB
PREDNISONE DOK5

Interaction Score: 0.36

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
26590194

Sources:
PharmGKB
PREDNISONE BMP7

Interaction Score: 0.36

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
26590194

Sources:
PharmGKB
PREDNISONE TPMT

Interaction Score: 0.36

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
16044099

Sources:
PharmGKB
PREDNISONE PTPRC

Interaction Score: 0.3

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
17063711

Sources:
NCI
PREDNISONE GATA3

Interaction Score: 0.27

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
24141364

Sources:
PharmGKB
PREDNISONE VWF

Interaction Score: 0.22

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
3146197

Sources:
NCI
PREDNISONE CTLA4

Interaction Score: 0.2

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
21228734

Sources:
PharmGKB
PREDNISONE TG

Interaction Score: 0.2

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
2745931

Sources:
NCI
PREDNISONE IFNG

Interaction Score: 0.19

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10784002

Sources:
NCI
PREDNISONE ITGB2

Interaction Score: 0.19

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
8976974

Sources:
NCI
PREDNISONE APOE

Interaction Score: 0.18

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
3185288

Sources:
NCI
PREDNISONE NR3C1

Interaction Score: 0.16

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

Direct Interaction? True

PMIDs:
17504182 17062674 15634032 16707595 11752352 16597193 17121036

Sources:
TEND DTC TdgClinicalTrial TTD DrugBank GuideToPharmacology ChemblInteractions
PREDNISONE CALCA

Interaction Score: 0.14

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11475715

Sources:
NCI
PREDNISONE GSTM1

Interaction Score: 0.14

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11186134

Sources:
NCI
PREDNISONE TYMSOS

Interaction Score: 0.14

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
PREDNISONE ANXA1

Interaction Score: 0.06

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TEND
PREDNISONE GSTP1

Interaction Score: 0.06

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11186134

Sources:
NCI
PREDNISONE TYMS

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
PREDNISONE ABCB1

Interaction Score: 0.02

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
12175731 25637052

Sources:
PharmGKB
PREDNISONE CYP2C9

Interaction Score: 0.01

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22931300

Sources:
DTC
PREDNISONE CYP1A2

Interaction Score: 0.01

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22931300

Sources:
DTC
PREDNISONE CYP2D6

Interaction Score: 0.01

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22931300

Sources:
DTC
PREDNISONE HSD17B10

Interaction Score: 0.0

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
PREDNISONE CYP3A4

Interaction Score: 0.0

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22931300

Sources:
DTC
PREDNISONE CYP2C19

Interaction Score: 0.0

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
PREDNISONE AR

Interaction Score: 0.0

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC

DrugBank: DB00635

Version: 5.1.7

Alternate Names:

PREDNISONE DrugBank Drug Name

53-03-2 CAS Number

Alti-prednisone Tab 5mg Drug Brand

Drug Info:

Drug Type small molecule

Drug Groups approved

Drug Groups vet_approved

Publications:

Díez et al., 2007, Pharmacological therapy of Cushing's syndrome: drugs and indications., Mini Rev Med Chem

Yano et al., 2006, Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells., Clin. Cancer Res.

Czock D et al., 2005, Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids., Clin Pharmacokinet

TEND: PREDNISONE
- Version: 01-August-2011
Alternate Names:

PREDNISONE Primary Drug Name

Drug Info:

Drug Class anti-inflammatory agents

Year of Approval approved before 1982

Drug Class glucocorticoids

Publications:
TdgClinicalTrial: PREDNISONE
- Version: January-2014
Alternate Names:

Drug Info:

Drug Indications antiinflammatory agent,corticosteroid

Drug Class Small Molecule

FDA Approval approved

Publications:

NCI: PREDNISONE

Version: 14-September-2017

Alternate Names:

C770 NCI drug code

Drug Info:

Publications:

Ettinger et al., 1988, Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men., Metab. Clin. Exp.

Anderer et al., 2000, Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia., Pharmacogenetics

Fracchia et al., 2000, Serum interferon gamma in primary biliary cirrhosis: effect of ursodeoxycholic acid and prednisone therapy alone and in combination., Eur J Gastroenterol Hepatol

DTC: PREDNISONE
- Version: 02-September-2020
Alternate Names:

CHEMBL635 ChEMBL Drug ID

Drug Info:

Publications:

Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol

PharmGKB: prednisone

Version: 18-August-2020

Alternate Names:

Drug Info:

Publications:

Kurzawski M et al., 2005, The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients., Ther Drug Monit

Perez-Andreu V et al., 2013, Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse., Nat Genet

Favis R et al., 2011, Genetic variation associated with bortezomib-induced peripheral neuropathy., Pharmacogenet Genomics

TTD: Prednisone
- Version: 2020.06.01
Alternate Names:

D0IL7L TTD Drug ID

Drug Info:

Publications:
GuideToPharmacology: 178103674
- Version: 29-September-2020
Alternate Names:

PREDNISONE GuideToPharmacology Ligand Name

Drug Info:

Publications:
ChemblDrugs: chembl:CHEMBL635
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:
ChemblInteractions: CHEMBL635
- Version: chembl_23
Alternate Names:

Drug Info:

Publications:

Specific Action of the Ligand	Full agonist
Endogenous Drug?	False
Direct Interaction?	True

PREDNISONE	DrugBank Drug Name
53-03-2	CAS Number
Alti-prednisone Tab 5mg	Drug Brand

Drug Type	small molecule
Drug Groups	approved
Drug Groups	vet_approved

PREDNISONE Drug Record

PREDNISONE chembl:CHEMBL635 ApprovedAntineoplasticImmunotherapy

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 10612091

Sources: NCI

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 24614921

Sources: PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 27173875

Sources: PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 9112644

Sources: NCI

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 29938344 19448608

Sources: PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 26590194

Sources: PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 26590194

Sources: PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 26590194

Sources: PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 16044099

Sources: PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 17063711

Sources: NCI

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 24141364

Sources: PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 3146197

Sources: NCI

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 21228734

Sources: PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 2745931

Sources: NCI

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 10784002

Sources: NCI

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 8976974

Sources: NCI

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 3185288

Sources: NCI

Interaction Types & Directionality: agonist (activating)

Interaction Info: Specific Action of the Ligand Full agonist Endogenous Drug? False Direct Interaction? True

PMIDs: 17504182 17062674 15634032 16707595 11752352 16597193 17121036

Sources: TEND DTC TdgClinicalTrial TTD DrugBank GuideToPharmacology ChemblInteractions

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 11475715

Interaction Types & Directionality:

n/a

PMIDs:
10612091

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
24614921

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
27173875

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
9112644

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
29938344 19448608

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
26590194

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
26590194

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
26590194

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
16044099

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
17063711

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
24141364

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
3146197

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
21228734

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
2745931

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
10784002

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
8976974

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
3185288

Sources:
NCI

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

Direct Interaction? True

PMIDs:
17504182 17062674 15634032 16707595 11752352 16597193 17121036

Sources:
TEND DTC TdgClinicalTrial TTD DrugBank GuideToPharmacology ChemblInteractions

Interaction Types & Directionality:

n/a

PMIDs:
11475715

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
11186134

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
TEND

Interaction Types & Directionality:

n/a

PMIDs:
11186134

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
12175731 25637052

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
22931300

Sources:
DTC

Interaction Types & Directionality:

n/a